Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02997293 · ClinicalTrials.gov registry record
Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery
A clinical trial of ColoRectal Cancer and Inflammatory Bowel Disease, sponsored by University of Arkansas.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT02997293: Recruiting study of ColoRectal Cancer and Inflammatory Bowel Disease, sponsored by University of Arkansas.
NCT02997293 is a study of ColoRectal Cancer and Inflammatory Bowel Disease that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02997293, a study of ColoRectal Cancer and Inflammatory Bowel Disease, is actively recruiting participants, sponsored by University of Arkansas.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study to look at the impact of the Enhanced Recovery After Surgery system for colorectal surgery (Group 1) in shortening hospital length of stay, reducing postoperative narcotic consumption, lowering Visual Analog Scale scores, decreasing the incidence of postoperative nausea and vomiting, and reducing 30-day readmission when compared to patients who had colorectal surgery performed at UAMS prior to the implementation of the Enhanced Recovery After Surgery system (Group 2). This is a retrospective study using de-identified records and therefore will not require subject enrollment and is NOT Human Subjects Research.
Primary Outcome
To compare the hospital length of stay following major colorectal surgery at the University of Arkansas for Medical Sciences for patients who had their perioperative care guided by the principles of the Enhanced Recovery After Surgery system to those that had major colorectal surgery at University of Arkansas for Medical Sciences prior to the implementation of the Enhanced Recovery After Surgery system.
Conditions Studied
Interventions
- OTHER Enhanced Recovery protocol
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2028-07-01 |
What NCT02997293 shows while recruiting
NCT02997293 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with ColoRectal Cancer and Inflammatory Bowel Disease appearing as the primary indexed condition, and to 1 intervention - of which Enhanced Recovery protocol is the first listed.
NCT02997293 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT02997293 about?
NCT02997293 is a clinical study titled "Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery". This is an observational study to look at the impact of the Enhanced Recovery After Surgery system for colorectal surgery (Group 1) in shortening hospital length of stay, reducing postoperative narcotic consumption, lowering Visual Analog Scale scores, decreasing the incidence of postoperative nause...
What is the current status of trial NCT02997293?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2017-03-01. Estimated completion is 2028-07-01.
What conditions does trial NCT02997293 study?
This clinical trial studies the following conditions: ColoRectal Cancer and Inflammatory Bowel Disease.
What interventions are being tested in trial NCT02997293?
The interventions under investigation include: Enhanced Recovery protocol (OTHER).
Who is sponsoring clinical trial NCT02997293?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02997293 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI